Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.

Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW.

J Clin Endocrinol Metab. 2004 Jun;89(6):2867-72.

PMID:
15181070
2.

Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.

Cañadas-Garre M, Becerra-Massare P, López de la Torre-Casares M, Villar-del Moral J, Céspedes-Mas S, Vílchez-Joya R, Muros-de Fuentes T, García-Calvente C, Piédrola-Maroto G, López-Nevot MA, Montes-Ramírez R, Llamas-Elvira JM.

Ann Surg. 2012 May;255(5):986-92. doi: 10.1097/SLA.0b013e31824e8d70.

PMID:
22504197
3.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.

Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6.

PMID:
17054470
4.

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.

Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R.

J Clin Oncol. 2009 Jun 20;27(18):2977-82. doi: 10.1200/JCO.2008.20.1426. Epub 2009 May 4.

5.

[BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens].

Dujardin F, Pagès JC, Collin C, de Calan L, Lecomte P, Guyétant S.

Ann Pathol. 2010 Aug;30(4):252-62. doi: 10.1016/j.annpat.2010.05.011. Epub 2010 Jul 29. French.

PMID:
20837233
6.

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC.

Eur J Endocrinol. 2009 Sep;161(3):467-73. doi: 10.1530/EJE-09-0353. Epub 2009 Jul 2.

7.

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.

Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M.

Clin Endocrinol (Oxf). 2007 May;66(5):678-83. Epub 2007 Mar 23.

PMID:
17381488
8.

Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.

Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C.

Thyroid. 2007 Nov;17(11):1109-15.

PMID:
17727338
9.

Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.

Joo JY, Park JY, Yoon YH, Choi B, Kim JM, Jo YS, Shong M, Koo BS.

J Clin Endocrinol Metab. 2012 Nov;97(11):3996-4003. doi: 10.1210/jc.2012-2444. Epub 2012 Aug 28.

PMID:
22930785
10.

Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.

Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M.

Cancer Cytopathol. 2014 Jan;122(1):48-58. doi: 10.1002/cncy.21352. Epub 2013 Sep 4.

12.

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.

Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS.

Diagn Mol Pathol. 2008 Jun;17(2):118-25. doi: 10.1097/PDM.0b013e31815d059d.

PMID:
18382358
13.

BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.

Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C.

Clin Chem Lab Med. 2011 Feb;49(2):325-9. doi: 10.1515/CCLM.2011.031. Epub 2010 Dec 23.

PMID:
21175381
14.

Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area.

Kwak JY, Kim EK, Kim JK, Han JH, Hong SW, Park TS, Choi JR.

Head Neck. 2010 Apr;32(4):490-8. doi: 10.1002/hed.21210.

PMID:
19672964
15.

Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.

Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.

J Clin Endocrinol Metab. 2012 Jul;97(7):2354-61. doi: 10.1210/jc.2011-3494. Epub 2012 Apr 24.

PMID:
22535974
16.

Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.

Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M, Motta M, Troncone G, Caleo A, Vallefuoco P, Rossi G, Fenzi G, Vitale M.

Endocr Relat Cancer. 2007 Dec;14(4):1089-97.

17.

Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.

PMID:
22500044
18.

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.

Thyroid. 2011 Jul;21(7):717-23. doi: 10.1089/thy.2011.0021. Epub 2011 May 13.

PMID:
21568726
19.

Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis.

Nechifor-Boilă A, Decaussin-Petrucci M, Gazzo S, Paşcanu I, Borda A.

Rom J Morphol Embryol. 2012;53(2):263-7.

20.

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.

Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.

Supplemental Content

Support Center